Análisis Argos
CUBE
CUBEEn su precio2 señales de riesgo
CubeSmart · Real Estate
US$ 40.98
precio al 2026-07-04
Valor justo Argos*
US$ 34–38
vs. su valor justo
9% por encima
Score Argos
45/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (6.8%) en línea con lo que la empresa demuestra (2.4%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Cotiza 19% por debajo de su valor justo.
Reparte dividendo sostenible (5.15%).
Riesgos
!Altman Z'' en zona roja (0.12)
!Beneish M-Score sugiere manipulación (-1.65)
VALOR3/6FUTURO3/6PASADO3/6SALUD0/6DIVIDENDO4/6
El Iris de calidad
VALOR3/6FUTURO3/6PASADO3/6SALUD0/6DIVIDENDO4/6
ValorCerca de su valor justo
FuturoCrecimiento moderado
PasadoHistorial aceptable
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos45de 100En su precio
Ingresos5%
US$ 1.1 B
Margen operativo12%
40%
Flujo de caja libre10%
US$ 0.6 B
Deuda neta
US$ 3.5 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 9.3B
P/E27.9x
EV/EBITDA18.2x
FCF yield6.1%
ROIC7.2%
Margen operativo40%
Crecim. ingresos+5.3%/año
Piotroski F5/9
Novedades

Noticias recientes

zacks.com · 8 jun
SBRA vs. CUBE: Which Stock Is the Better Value Option?
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Sabra Healthcare (SBRA) or CubeSmart (CUBE). But which of these two stocks offers value investors a better bang for their buck right now?
seekingalpha.com · 29 may
CubeSmart: Waiting For A Better Entry Point (Rating Downgrade)
CubeSmart is rated 'Hold' as its current valuation closely matches intrinsic value amid macro uncertainty. CUBE offers a solid 5.3% dividend yield and maintains a normal balance sheet for a REIT but still faces headwinds from a potentially higher-for-longer interest rate environment and questionable near-term demand. Industry supply pressures are moderating, with management expecting gradual improvement in 2026, yet no near-term demand catalyst is evident.
zacks.com · 22 may
DEI vs. CUBE: Which Stock Is the Better Value Option?
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Douglas Emmett (DEI) or CubeSmart (CUBE). But which of these two companies is the best option for those looking for undervalued stocks?
globenewswire.com · 19 may
CubeSmart Declares Second Quarter 2026 Dividend
MALVERN, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- CubeSmart (NYSE: CUBE) announced today that its Board of Trustees declared a quarterly dividend of $0.53 per common share for the period ending June 30, 2026. The dividend is payable on July 15, 2026 to common shareholders of record on July 1, 2026.
zacks.com · 6 may
DEI vs. CUBE: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Douglas Emmett (DEI) and CubeSmart (CUBE). But which of these two stocks is more attractive to value investors?
seekingalpha.com · 3 may
REITs Excel, Earnings Swell, Fed Rebels
U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.
seekingalpha.com · 1 may
CubeSmart (CUBE) Q1 2026 Earnings Call Transcript
CubeSmart (CUBE) Q1 2026 Earnings Call Transcript
zacks.com · 30 abr
CubeSmart (CUBE) Surpasses Q1 FFO and Revenue Estimates
CubeSmart (CUBE) came out with quarterly funds from operations (FFO) of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to FFO of $0.64 per share a year ago.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.